While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective treatments for decades. The brains of people who die with Alzheimer’s show a ...

Long-term benzodiazepine use in older adults disrupts sleep patterns, leading to lighter sleep and potential cognitive ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

Novo Nordisk A/S ( NOV) R&D Investor Event Call September 17, 2025 12:30 PM EDT Okay. We are good to go. Welcome to this Novo Nordisk fireside at the 61st Edition of EASD here in Vienna. Welcome to ...

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company of the field.

A new study published in Nature Mental Health provides initial evidence that the psychedelic compound ibogaine may alter ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between ...

Taste receptors are specialized proteins that facilitate the sense of taste. There are different groups of receptors for ...

Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as ligands, ...

The Yezdi name is synonymous with India’s motorcycling heritage , but its recent comeback has been met with mixed results. While the revival stirred nostalgia, the brand has struggled to make the kind ...

Apple has made another significant stride toward the public launch of iOS 26 with the release of Beta 7. This update introduces subtle yet meaningful refinements to features, design, and performance, ...